• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性硬化症复合物 2 的稳定性受 R1457 和 R1459 处的甲基化控制。

Stability of tuberous sclerosis complex 2 is controlled by methylation at R1457 and R1459.

机构信息

Laboratory of Nutritional Biochemistry, Department of Agricultural Chemistry, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo, 156-8502, Japan.

出版信息

Sci Rep. 2020 Dec 3;10(1):21160. doi: 10.1038/s41598-020-78274-6.

DOI:10.1038/s41598-020-78274-6
PMID:33273660
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7713242/
Abstract

Mutations in genes that encode components of tuberous sclerosis complex 2 (TSC2) are associated with tuberous sclerosis complex disease. TSC2 interacts with tuberous sclerosis complex 1 to form a complex that negatively regulates cell growth and proliferation via the inactivation of mechanistic target of rapamycin complex 1. The activity of TSC2 is mainly regulated via posttranslational modifications such as phosphorylation. However, the control of TSC2 activity is not entirely achieved by phosphorylation. In this study, we show that TSC2 is methylated at R1457 and R1459 by protein arginine methyltransferase 1 (PRMT1). Methylation of these two residues can affect the phosphorylation status through protein kinase B (Akt) of TSC2 at T1462 and is essential for TSC2 stability. Taken together, these findings indicate that novel posttranslational modifications are important for the regulation of TSC2 stability through PRMT1-mediated methylation.

摘要

基因突变编码结节性硬化症复合物 2 (TSC2) 的成分与结节性硬化症有关。TSC2 与结节性硬化症复合物 1 相互作用形成一个复合物,通过抑制雷帕霉素靶蛋白复合物 1 的失活来负调控细胞生长和增殖。TSC2 的活性主要通过翻译后修饰(如磷酸化)来调节。然而,TSC2 活性的控制并非完全通过磷酸化来实现。在这项研究中,我们表明 TSC2 被蛋白精氨酸甲基转移酶 1(PRMT1)在 R1457 和 R1459 处甲基化。这两个残基的甲基化可以通过 TSC2 的蛋白激酶 B(Akt)在 T1462 处影响磷酸化状态,并且对 TSC2 的稳定性是必需的。总之,这些发现表明,通过 PRMT1 介导的甲基化,新的翻译后修饰对 TSC2 稳定性的调节很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770c/7713242/cd99c0af1fca/41598_2020_78274_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770c/7713242/aaf8f79a5cda/41598_2020_78274_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770c/7713242/60f71bfea0b3/41598_2020_78274_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770c/7713242/d0f12e8ee36d/41598_2020_78274_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770c/7713242/cd99c0af1fca/41598_2020_78274_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770c/7713242/aaf8f79a5cda/41598_2020_78274_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770c/7713242/60f71bfea0b3/41598_2020_78274_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770c/7713242/d0f12e8ee36d/41598_2020_78274_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770c/7713242/cd99c0af1fca/41598_2020_78274_Fig4_HTML.jpg

相似文献

1
Stability of tuberous sclerosis complex 2 is controlled by methylation at R1457 and R1459.结节性硬化症复合物 2 的稳定性受 R1457 和 R1459 处的甲基化控制。
Sci Rep. 2020 Dec 3;10(1):21160. doi: 10.1038/s41598-020-78274-6.
2
Methionine controls insulin/mammalian target of rapamycin complex 1 activity by modulating tuberous sclerosis complex 2 stability.蛋氨酸通过调节结节性硬化复合物 2 的稳定性来控制胰岛素/哺乳动物雷帕霉素靶蛋白复合物 1 的活性。
Biochem Biophys Res Commun. 2021 Feb 19;541:84-89. doi: 10.1016/j.bbrc.2021.01.033. Epub 2021 Jan 20.
3
Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt.BCL-2 凋亡蛋白拮抗剂(BAD)的精氨酸甲基化拮抗 Akt 的磷酸化及其失活。
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6085-90. doi: 10.1073/pnas.1015328108. Epub 2011 Mar 28.
4
Polymerized collagen inhibits fibroblast proliferation via a mechanism involving the formation of a beta1 integrin-protein phosphatase 2A-tuberous sclerosis complex 2 complex that suppresses S6K1 activity.聚合胶原蛋白通过一种机制抑制成纤维细胞增殖,该机制涉及形成一种抑制S6K1活性的β1整合素-蛋白磷酸酶2A-结节性硬化复合物2复合物。
J Biol Chem. 2008 Jul 18;283(29):20350-60. doi: 10.1074/jbc.M707489200. Epub 2008 May 16.
5
14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin.14-3-3β与结节性硬化复合物2(TSC2)肿瘤抑制基因产物结节蛋白结合并对其起负调控作用。
J Biol Chem. 2003 Jan 24;278(4):2089-92. doi: 10.1074/jbc.C200499200. Epub 2002 Dec 4.
6
SCYL1 arginine methylation by PRMT1 is essential for neurite outgrowth via Golgi morphogenesis.PRMT1介导的SCYL1精氨酸甲基化通过高尔基体形态发生对神经突生长至关重要。
Mol Biol Cell. 2020 Aug 15;31(18):1963-1973. doi: 10.1091/mbc.E20-02-0100. Epub 2020 Jun 17.
7
Critical role of T-loop and H-motif phosphorylation in the regulation of S6 kinase 1 by the tuberous sclerosis complex.T环和H基序磷酸化在结节性硬化复合物对S6激酶1的调控中的关键作用。
J Biol Chem. 2004 May 14;279(20):20816-23. doi: 10.1074/jbc.M400957200. Epub 2004 Mar 1.
8
Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin.结节性硬化症复合物1和2基因产物的失活是通过磷酸肌醇3激酶/蛋白激酶B对结节蛋白的依赖性和非依赖性磷酸化而发生的。
J Biol Chem. 2003 Sep 26;278(39):37288-96. doi: 10.1074/jbc.M303257200. Epub 2003 Jul 16.
9
Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis.结节性硬化复合物2(TSC2)N端结构为复合物组装及结节性硬化症发病机制提供了见解。
J Biol Chem. 2016 Sep 16;291(38):20008-20. doi: 10.1074/jbc.M116.732446. Epub 2016 Aug 4.
10
Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.Akt 通过调节细胞内 ATP 水平和 AMPK 活性来激活雷帕霉素的哺乳动物靶点。
J Biol Chem. 2005 Sep 16;280(37):32081-9. doi: 10.1074/jbc.M502876200. Epub 2005 Jul 15.

引用本文的文献

1
New insights into tuberous sclerosis complex: from structure to pathogenesis.结节性硬化症的新见解:从结构到发病机制
Front Cell Dev Biol. 2025 Jun 27;13:1595867. doi: 10.3389/fcell.2025.1595867. eCollection 2025.
2
The role of TSC2 in breast cancer: a literature review.结节性硬化症复合物2(TSC2)在乳腺癌中的作用:文献综述
Front Oncol. 2023 May 12;13:1188371. doi: 10.3389/fonc.2023.1188371. eCollection 2023.
3
mTORC1 Activity in Psoriatic Lesions Is Mediated by Aberrant Regulation through the Tuberous Sclerosis Complex.

本文引用的文献

1
Methionine Restriction and Cancer Biology.甲硫氨酸限制与癌症生物学。
Nutrients. 2020 Mar 3;12(3):684. doi: 10.3390/nu12030684.
2
Calcium-dependent methylation by PRMT1 promotes erythroid differentiation through the p38α MAPK pathway.PRMT1 通过钙依赖性甲基化促进红细胞分化通过 p38α MAPK 通路。
FEBS Lett. 2020 Jan;594(2):301-316. doi: 10.1002/1873-3468.13614. Epub 2019 Oct 10.
3
AKT/PKB Signaling: Navigating the Network.AKT/蛋白激酶B信号传导:探索该网络
银屑病皮损中 mTORC1 的活性是通过结节性硬化复合物的异常调节介导的。
Cells. 2022 Sep 13;11(18):2847. doi: 10.3390/cells11182847.
4
Programmed Cell Death in Diabetic Nephropathy: A Review of Apoptosis, Autophagy, and Necroptosis.糖尿病肾病中的细胞程序性死亡:细胞凋亡、自噬和坏死性凋亡的综述。
Med Sci Monit. 2022 Aug 22;28:e937766. doi: 10.12659/MSM.937766.
5
Dissecting the roles of the Tuberin protein in the subcellular localization of the G2/M Cyclin, Cyclin B1.解析 Tuberin 蛋白在 G2/M 周期蛋白 Cyclin B1 亚细胞定位中的作用。
PLoS One. 2022 Aug 10;17(8):e0272741. doi: 10.1371/journal.pone.0272741. eCollection 2022.
6
Structure, Activity, and Function of PRMT1.蛋白精氨酸甲基转移酶1的结构、活性与功能
Life (Basel). 2021 Oct 27;11(11):1147. doi: 10.3390/life11111147.
7
How Protein Methylation Regulates Steroid Receptor Function.蛋白质甲基化如何调节甾体激素受体功能。
Endocr Rev. 2022 Jan 12;43(1):160-197. doi: 10.1210/endrev/bnab014.
Cell. 2017 Apr 20;169(3):381-405. doi: 10.1016/j.cell.2017.04.001.
4
Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.二甲双胍通过涉及AMPK和TSC复合物的剂量依赖性机制抑制肝脏mTORC1信号传导。
Cell Metab. 2017 Feb 7;25(2):463-471. doi: 10.1016/j.cmet.2016.12.009. Epub 2017 Jan 12.
5
Arginine Methylation: The Coming of Age.精氨酸甲基化:崭露头角。
Mol Cell. 2017 Jan 5;65(1):8-24. doi: 10.1016/j.molcel.2016.11.003.
6
Using oriented peptide array libraries to evaluate methylarginine-specific antibodies and arginine methyltransferase substrate motifs.使用定向肽阵列文库评估精氨酸特异性抗体和精氨酸甲基转移酶底物基序。
Sci Rep. 2016 Jun 24;6:28718. doi: 10.1038/srep28718.
7
Tuberous sclerosis complex.结节性硬化症。
Nat Rev Dis Primers. 2016 May 26;2:16035. doi: 10.1038/nrdp.2016.35.
8
Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis.长期高脂肪生酮饮食促进结节性硬化症大鼠模型肾肿瘤生长。
Sci Rep. 2016 Feb 19;6:21807. doi: 10.1038/srep21807.
9
Biochemistry and regulation of the protein arginine methyltransferases (PRMTs).蛋白质精氨酸甲基转移酶(PRMTs)的生物化学与调控
Arch Biochem Biophys. 2016 Jan 15;590:138-152. doi: 10.1016/j.abb.2015.11.030. Epub 2015 Dec 2.
10
The tuberous sclerosis complex model Eker (TSC2+/-) rat exhibits hyperglycemia and hyperketonemia due to decreased glycolysis in the liver.结节性硬化症复合模型埃克(TSC2+/-)大鼠由于肝脏糖酵解减少而出现高血糖和高酮血症。
Arch Biochem Biophys. 2016 Jan 15;590:48-55. doi: 10.1016/j.abb.2015.10.019. Epub 2015 Nov 6.